Skip to main content
Clinical Trials/NCT05758844
NCT05758844RecruitingNot Applicable

The Safe-line Technique as Additional Attempt to Mitigate Spinal Cord Ischemia After Endovascular Thoraco-abdominal Aneurysm Repair

University Hospital Padova1 site in 1 country100 target enrollmentStarted: April 30, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
100
Locations
1
Primary Endpoint
Incidence of adverse events

Study Overview

Brief Summary

To assess safety and feasebility of the "safe-line" technique in a multicenter international collaboration.

Detailed Description

To assess safety and efficacy of a technique for temporary aneurysm sac re-perfusion (TASreP) after total endovascular exclusion of TAAA, using a guide-wire left into the aneurysm sac. The technique can be applied both in elective that urgent cases.

The guide-wire aim to be a "safe-line" for fast temporary trans-sealing aneurysm sac re-perfusion in case of SCI occurring in the early post-operative period (48-to 72h).

Before completing exclusion, from the percutaneous femoral access, a second buddy-wire (V-18 guidewire; Boston Scientific) is advanced and left posterior to the endograft into the aneurysmal sac; through the main guide-wire, the final aneurysm exclusion is completed with distal stent-graft deployment and the femoral access sealed with Proglide leaving in place the sole V.018 draped in a sterile fashion. In the case of SCI occurrence in the post-operative period up to 48-72 hrs, the trans-sealing V.18 "safe-line" can be rapidly exchanged with a 6F/65 cm long Destination cm guiding sheath (Terumo) and positioned into the aneurysmal sac; this can be connected to a 6F introducer from the contralateral femoral artery and the sac perfused in a retrograde fashion.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Thoraco-abdominal aortic aneurysm including type I,II,III,IV and V.
  • Pararenale aneurysm
  • Thoracoabdominal aortic aneurysm Elective and Urgent, endovascular repair;
  • Endovascular repair of any thoracoabdominal aortic condition

Exclusion Criteria

  • thoraco-abdominal aortic aneurysm open repair

Outcomes

Primary Outcomes

Incidence of adverse events

Time Frame: 7 days

collect eventual complications (incidence of: 1- axis thrombosis; 2- microembolization; 3-hematoma)

Incidence of spinal cord ischemia improvement or resolution

Time Frame: 30 days

collect all events that in case of post-operative (48-72hrs) spinal cord ischemia had symptoms mitigation (1-paraplegia improvement; 2 - paraplegia complete resolution)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michele Piazza

Associate Professor

University Hospital Padova

Study Sites (1)

Loading locations...

Similar Trials